Form D · Other Health Care

Retropsoas Technologies, LLC

Frontenac, MO · CIK 0001798662

Offering snapshot reported May 4, 2026 · SEC filing

Reported sold
$3.11M
Offering amount: $4.5M
Investors reported
38
Form D · investor count
Minimum accepted
$25K
Reported outside-investor minimum
First sale
Jan 15, 2025
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.56M$3.11MAug 22, 2025: $1,150,000.00Aug 22, 2025Dec 29, 2025: $1,425,000.00Dec 29, 2025May 4, 2026: $3,112,500.00May 4, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,425,000 → $3,112,500
  • Reported investors7 → 38

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 4, 2026Amendment$3,112,500$1,687,500vs Dec 29, 202538SEC filing
Dec 29, 2025Amendment$1,425,000$275,000vs Aug 22, 20257SEC filing
Aug 22, 2025Amendment$1,150,000No comparison5SEC filing
Jan 27, 2025Initial$1,050,000No comparison2SEC filing
Dec 30, 2022Amendment$1,280,000$200,000vs Jan 3, 20226SEC filing
Jan 3, 2022Amendment$1,080,000$180,000vs Dec 31, 20205SEC filing
Dec 31, 2020Amendment$900,000$600,000vs Jan 3, 20203SEC filing
Jan 3, 2020Initial$300,000No comparison1SEC filing

Offering details

Securities
Equity, Debt
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$1.75K
Finders' fees
$0
Form D file number
021-536374

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Wilmington Capital Securities, LLC133839

Source: Form D, filed May 4, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Nicholas E Poulos Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
34 Countryside Lane
Frontenac, MO, 63131